192 related articles for article (PubMed ID: 15189347)
1. 3,4-Methylenedioxymethamphetamine increases interleukin-1beta levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5-HT depletion.
Orio L; O'Shea E; Sanchez V; Pradillo JM; Escobedo I; Camarero J; Moro MA; Green AR; Colado MI
J Neurochem; 2004 Jun; 89(6):1445-53. PubMed ID: 15189347
[TBL] [Abstract][Full Text] [Related]
2. A study on the mechanisms by which minocycline protects against MDMA ('ecstasy')-induced neurotoxicity of 5-HT cortical neurons.
Orio L; Llopis N; Torres E; Izco M; O'Shea E; Colado MI
Neurotox Res; 2010 Aug; 18(2):187-99. PubMed ID: 19777321
[TBL] [Abstract][Full Text] [Related]
3. The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.
Mechan AO; Esteban B; O'Shea E; Elliott JM; Colado MI; Green AR
Br J Pharmacol; 2002 Jan; 135(1):170-80. PubMed ID: 11786492
[TBL] [Abstract][Full Text] [Related]
4. Evidence that MDMA ('ecstasy') increases cannabinoid CB2 receptor expression in microglial cells: role in the neuroinflammatory response in rat brain.
Torres E; Gutierrez-Lopez MD; Borcel E; Peraile I; Mayado A; O'Shea E; Colado MI
J Neurochem; 2010 Apr; 113(1):67-78. PubMed ID: 20067581
[TBL] [Abstract][Full Text] [Related]
5. Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain.
O'Shea E; Esteban B; Camarero J; Green AR; Colado MI
Neuropharmacology; 2001; 40(1):65-74. PubMed ID: 11077072
[TBL] [Abstract][Full Text] [Related]
6. Changes in interleukin-1 signal modulators induced by 3,4-methylenedioxymethamphetamine (MDMA): regulation by CB2 receptors and implications for neurotoxicity.
Torres E; Gutierrez-Lopez MD; Mayado A; Rubio A; O'Shea E; Colado MI
J Neuroinflammation; 2011 May; 8():53. PubMed ID: 21595923
[TBL] [Abstract][Full Text] [Related]
7. Studies on the mechanisms underlying amiloride enhancement of 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats.
Goñi-Allo B; Puerta E; Hervias I; Di Palma R; Ramos M; Lasheras B; Aguirre N
Eur J Pharmacol; 2007 May; 562(3):198-207. PubMed ID: 17320075
[TBL] [Abstract][Full Text] [Related]
8. The relationship between hyperthermia and glycogenolysis in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats.
Darvesh AS; Gudelsky GA
Neurotoxicol Teratol; 2004; 26(4):571-7. PubMed ID: 15203179
[TBL] [Abstract][Full Text] [Related]
9. The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain.
Sanchez V; Camarero J; Esteban B; Peter MJ; Green AR; Colado MI
Br J Pharmacol; 2001 Sep; 134(1):46-57. PubMed ID: 11522596
[TBL] [Abstract][Full Text] [Related]
10. Repeated intermittent methylenedioxymethamphetamine exposure protects against the behavioral and neurotoxic, but not hyperthermic, effects of an MDMA binge in adult rats.
Piper BJ; Ali SF; Daniels LG; Meyer JS
Synapse; 2010 Jun; 64(6):421-31. PubMed ID: 20169574
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a role of Hsp70 in the neuroprotection induced by heat shock pre-treatment against 3,4-methylenedioxymethamphetamine toxicity in rat brain.
Escobedo I; Peraile I; Orio L; Colado MI; O'Shea E
J Neurochem; 2007 Jun; 101(5):1272-83. PubMed ID: 17328712
[TBL] [Abstract][Full Text] [Related]
12. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.
Colado MI; Williams JL; Green AR
Br J Pharmacol; 1995 Aug; 115(7):1281-9. PubMed ID: 7582557
[TBL] [Abstract][Full Text] [Related]
13. Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter.
Kramer HK; Poblete JC; Azmitia EC
Neuropsychopharmacology; 1997 Sep; 17(3):117-29. PubMed ID: 9272479
[TBL] [Abstract][Full Text] [Related]
14. 3,4-Methylenedioxymethamphetamine increases pro-interleukin-1beta production and caspase-1 protease activity in frontal cortex, but not in hypothalamus, of Dark Agouti rats: role of interleukin-1beta in neurotoxicity.
O'Shea E; Sanchez V; Orio L; Escobedo I; Green AR; Colado MI
Neuroscience; 2005; 135(4):1095-105. PubMed ID: 16165281
[TBL] [Abstract][Full Text] [Related]
15. Increased interleukin-1β levels following low dose MDMA induces tolerance against the 5-HT neurotoxicity produced by challenge MDMA.
Mayado A; Torres E; Gutierrez-Lopez MD; Colado MI; O'Shea E
J Neuroinflammation; 2011 Nov; 8():165. PubMed ID: 22114930
[TBL] [Abstract][Full Text] [Related]
16. Gender differences in hyperthermia and regional 5-HT and 5-HIAA depletion in the brain following MDMA administration in rats.
Wallinga AE; Grahlmann C; Granneman RA; Koolhaas JM; Buwalda B
Brain Res; 2011 Jun; 1398():13-20. PubMed ID: 21620380
[TBL] [Abstract][Full Text] [Related]
17. Acute concomitant effects of MDMA binge dosing on extracellular 5-HT, locomotion and body temperature and the long-term effect on novel object discrimination in rats.
Rodsiri R; Spicer C; Green AR; Marsden CA; Fone KC
Psychopharmacology (Berl); 2011 Feb; 213(2-3):365-76. PubMed ID: 20645080
[TBL] [Abstract][Full Text] [Related]
18. The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA ('ecstasy') when housed at high ambient temperature.
Saadat KS; O'shea E; Colado MI; Elliott JM; Green AR
Psychopharmacology (Berl); 2005 Jun; 179(4):884-90. PubMed ID: 15650843
[TBL] [Abstract][Full Text] [Related]
19. Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain.
Izco M; Orio L; O'Shea E; Colado MI
Psychopharmacology (Berl); 2007 Jan; 189(4):459-70. PubMed ID: 17047928
[TBL] [Abstract][Full Text] [Related]
20. Repeated exposure to MDMA provides neuroprotection against subsequent MDMA-induced serotonin depletion in brain.
Bhide NS; Lipton JW; Cunningham JI; Yamamoto BK; Gudelsky GA
Brain Res; 2009 Aug; 1286():32-41. PubMed ID: 19555677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
